Deepak Shenoy says: "We have got very little in financials, very little in IT. I think those are the two areas and almost nothing in pharma in our fundamental driven strategies. And at this point, I will wait for results to finally come in. Things do not look as exciting as they were in the October news time when we saw the September quarter results come in."
